Registered entities
Biolytx Pharmaceuticals Corp
Reg. No. 371514075United States
Investor mix
6 investors on record; lead investors include i2E.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Angel & family office | 1 | 17% |
| Other / undisclosed | 3 | 50% |
Developing antimicrobial peptide drugs to combat antibiotic resistance and hospital-acquired infections
6 investors on record; lead investors include i2E.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Angel & family office | 1 | 17% |
| Other / undisclosed | 3 | 50% |